PPAR-γ Impairment Alters Peroxisome Functionality in Primary Astrocyte Cell Cultures
Figure 3
Catalase activity: effect of increasing concentrations of G3335. Astrocytes (2 105 cells/well) were treated with the reversible PPAR antagonist G3335 (1–100 μM) for 2 or 5 days. Values are expressed as the mean ± S.E.M. percent of control of three experiments. Control catalase activity was arbitrarily set as 100%. * in comparison to control conditions in the absence of treatment.
